Samsung Biologics seeks global expansion at Bio Int'l Convention
Samsung Biologics will participate in the 2024 Bio International Convention, the largest biopharmaceutical exhibition in the industry, to showcase its contract-based drug manufacturing and development capabilities, the company said Monday.
